Metastatic hormone-sensitive prostate cancer: clinical decision making in a rapidly evolving landscape of life-prolonging therapy
dc.contributor.author | VanderWeele, DJ | |
dc.contributor.author | Antonarakis, ES | |
dc.contributor.author | Carducci, MA | |
dc.contributor.author | Dreicer, R | |
dc.contributor.author | Fizazi, K | |
dc.contributor.author | Gillessen, Silke | |
dc.contributor.author | Higano, CS | |
dc.contributor.author | Morgans, AK | |
dc.contributor.author | Petrylak, DP | |
dc.contributor.author | Sweeney, CJ | |
dc.contributor.author | Hussain, M | |
dc.date.accessioned | 2019-10-07T15:16:42Z | |
dc.date.available | 2019-10-07T15:16:42Z | |
dc.date.issued | 2019 | en |
dc.identifier.citation | VanderWeele DJ, Antonarakis ES, Carducci MA, Dreicer R, Fizazi K, Gillessen S, et al. Metastatic hormone-sensitive prostate cancer: clinical decision making in a rapidly evolving landscape of life-prolonging therapy. J Clin Oncol. 2019 Sep 10:JCO1901595. | en |
dc.identifier.pmid | 31498754 | en |
dc.identifier.doi | 10.1200/JCO.19.01595 | en |
dc.identifier.uri | http://hdl.handle.net/10541/622199 | |
dc.language.iso | en | en |
dc.relation.url | https://dx.doi.org/10.1200/JCO.19.01595 | en |
dc.title | Metastatic hormone-sensitive prostate cancer: clinical decision making in a rapidly evolving landscape of life-prolonging therapy | en |
dc.type | Article | en |
dc.contributor.department | Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, | en |
dc.identifier.journal | Journal of Clinical Oncology | en |
dc.description.note | en] |